CONCLUSION
Our study showed that the application of CI in patients who underwent
chemoradiotherapy for NPC is relatively safe and feasible. The long-term
complications reported here, including mastoiditis, ORNTB, and REP, are
not absolute surgical contraindications. MDT has an important role in
the whole process of diagnosis and treatment, which can rapidly reduce
the perioperative risk, effectively predict the postoperative auditory
effect, and prevent the occurrence of postoperative complications.